Christophe Schilling | AIChE

Christophe Schilling


Christophe founded Genomatica in 1998. Since being named CEO in May 2009, he has led Genomatica to widespread recognition as a leader in industrial biotech, with a commercialized first process and plant (for 1,4-butanediol), a second process in early commercialization (for Brontide™ butylene glycol, winner of the ICIS Innovation Award), and multiple leading partners.

The company has earned awards for industry impact (ICIS Top40 Power Players six years in a row, and highest rating for sustainability technology in 2017 ICIS survey), engineering (Kirkpatrick Award), science (EPA Presidential Green Chemistry), industry leadership (voted #1 Hottest in renewable chemicals four years in a row by Biofuels Digest), and company culture (The Scientist as a Best Place to Work).

Christophe is Chairman Elect for Biocom, the largest advocate organization for California’s life sciences sector; serves on the World Economic Forum Global Agenda Council on Biotechnology; and is a member of YPO, an international leadership organization for chief executives.

Christophe holds a Ph.D. in bioengineering from the University of California, San Diego. He received a B.S. in biomedical engineering from Duke University and was honored as a Distinguished Young Alumnus in 2010.